Selected article for: "accurate rapid and acute respiratory syndrome diagnosis"

Author: Han, Han; Wang, Chongwen; Yang, Xingsheng; Zheng, Shuai; Cheng, Xiaodan; Liu, Zhenzhen; Zhao, Baohua; Xiao, Rui
Title: Rapid field determination of SARS-CoV-2 by a colorimetric and fluorescent dual-functional lateral flow immunoassay biosensor
  • Cord-id: o9blbmb0
  • Document date: 2021_10_9
  • ID: o9blbmb0
    Snippet: The rapid and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the early stage of virus infection can effectively prevent the spread of the virus and control the epidemic. Here, a colorimetric and fluorescent dual-functional lateral flow immunoassay (LFIA) biosensor was developed for the rapid and sensitive detection of spike 1 (S1) protein of SARS-CoV-2. A novel dual-functional immune label was fabricated by coating a single-layer shell formed by mixing 20 n
    Document: The rapid and accurate diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the early stage of virus infection can effectively prevent the spread of the virus and control the epidemic. Here, a colorimetric and fluorescent dual-functional lateral flow immunoassay (LFIA) biosensor was developed for the rapid and sensitive detection of spike 1 (S1) protein of SARS-CoV-2. A novel dual-functional immune label was fabricated by coating a single-layer shell formed by mixing 20 nm Au nanoparticles (Au NPs) and quantum dots (QDs) on SiO(2) core to produce strong colorimetric and fluorescence signals and ensure good monodispersity and high stability. The colorimetric signal was used for visual detection and rapid screening of suspected SARS-CoV-2 infection on sites. The fluorescence signal was utilized for sensitive and quantitative detection of virus infection at the early stage. The detection limits of detecting S1 protein via colorimetric and fluorescence functions of the biosensor were 1 and 0.033 ng/mL, respectively. Furthermore, we evaluated the performance of the biosensor for analyzing real samples. The novel biosensor developed herein had good repeatability, specificity and accuracy, which showed great potential as a tool for rapidly detecting SARS-CoV-2.

    Search related documents:
    Co phrase search for related documents
    • acceptable accuracy and lod detection limit: 1
    • accurate rapid and acid nucleic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate rapid and acute ards respiratory distress syndrome: 1, 2, 3
    • accurate rapid and lod detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • accurate rapid and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate rapid detection and acid nucleic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate rapid detection and lod detection limit: 1, 2, 3, 4
    • accurate rapid detection and low sensitivity: 1, 2, 3, 4
    • accurate rapid method and acid nucleic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • accurate rapid method and lod detection limit: 1, 2, 3
    • accurate rapid method and low sensitivity: 1, 2, 3, 4
    • accurate rapid screening and acid nucleic: 1, 2, 3
    • accurate rapid screening and low sensitivity: 1
    • accurate sensitive and acid nucleic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • accurate sensitive and acute ards respiratory distress syndrome: 1, 2
    • accurate sensitive and lod detection limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • accurate sensitive and low sensitivity: 1, 2, 3, 4, 5, 6
    • acid nucleic and low coefficient: 1, 2
    • acid nucleic and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25